Pharm Exam I Flashcards
aka Cranial-sacral
Parasympathetic
aka Thoraco-lumbar
Sympathetic
Effector and Function of alpha-1
smooth muscles and sphincters
contraction (constriction)
Effector and Function of alpha-2
Nerve endings
decrease transmitter release
Effector and Function of Beta-1
cardiac muscle and kidney
increase HR and contractility, increase renin
Effector and Function of Beta-2
smooth muscle (bronchi), liver, and skeletal muscle
relax smooth muscle, gluconeogenesis, increase K+
Effector and Function of Beta-3
Adipose
increase lipolysis
Effector and Function of DA-1
Smooth muscle (renal), mesenteric, and cardiac
relax renal SM
- higher doses activates B1 and A1 receptors
Pathway of catecholamine biosynthesis
Phenylalanine
Tyrosine
Dopa
Dopamine
Norepinephrine
Epinephrine
All catecholamines are rapidly inactivated by ___ and ___
MAO ro COMT
- Monoamine oxidase
- catechol-O-methyltransferase
What drugs should not be given with MAO inhibitors?
- antihistamines
- antihypertensives
- barbituates
- CNS depressants
- OTC cold meds
- tricyclic antidepressants
3 common MAO inhibitors
Nardil, Parnate, and Marplan
(3) naturally occuring catecholamines
Epinephrine, Norepinephrine, and Dopamine
(2) non-catecholamine sympathomimetics
Ephedrine and Phenylephrine
(2) Synthetic catecholamines
Isoproterenol and Dobutamine
(3) selective Beta-2 agonists
albuterol, metaproterenol, and terbutaline
(1) cardiac glycoside
digoxin
(2) phosphodiesterase inhibitor
Amrinone and Milrinone
Epinephrine doses for Cardiac arrest
0.1 ml/kg of 1:1000 ETT
or
0.1 ml/kg of 1:10,000 IV
Epinephrine dose for Status Asthmaticus
0.01 mg/kg of 1:1000 sq
Epinephrine storage and release
adrenal medulla
Administration of Epinephrine
oral administration is not effective
- Must use sub-q, IV, IM, IO, or via ETT
Why does Epi not affect the brain?
poorly lipid soluble
Cardiovascular effects of Epineprhine
increases HR by accelerating rate of phase 4 depolarization
- increase risk of dysrhythmias
- chronic Epi reduces plasma volume
Respiratory effects of Epinephrine
Bronchodilator
- unless patient is BB, then it causes bronchoconstriction from stimulating bronchial alpha receptors
Other effects of Epinephrine
- most significant effect on metabolism
- may activate Na+-K+ pump and transfer K+ into cells
- mydriasis
- accelerates coagulation
- increases total leukocytes
- increases factor V
Which catecholamines have no effect on Alpha?
Isoproterenol and Dobutamine
Which catecholamines have the greatest effect on Alpha?
Norepinephrine and Phenylephrine
Which catecholamine has no effect on Beta-1
Phenylephrine
Which catecholamines have the most effect on Beta-1
isoproterenol and dobutamine
Which catecholamine has the most effect on Beta-2
Isoproterenol
Which catecholamine is indirect and direct
Ephedrine
Which catecholamines have a negative impact on CO and HR?
Norepinephrine and Phenylephrine
Which catecholamine has a large negative effect on peripheral vascular resistance?
Isoproterenol
Which two catecholamines cause the greatest increase in peripheral vascular resistance and MAP?
Norepinephrine and Phenylephrine
Synthesis and storage of Norepinephrine
postganglionic sympathetic nerve endings
Norepinephrine in treatment of refractory hypotension
continuous infusion (2-16 ug/min) in severe sepsis
Side effects of Norepinephrine
- avoid in right ventricular failure
- increase venous return to heart and increases the pulmonary artery pressure
- may decrease CO and increase work of left ventricle
Low dose Dopamine
(0.5 - 3 mcg/kg/min)
- primarily stimulates D1 and D2
- increases splanchnic and renal flow
- diuresis
negative side effects of Dopamine
- tachycardia in high doses
- increased pulmonary vascular resistance
- not good for right heart failure
- does NOT provide renal protection
- may cause harm in patients with renal disease by redistributing blood flow in the kidney
Clinical use for Dopamine
increase cardiac output in patients with decreased contractility, low systemic blood pressure and low urine output
Cardiovascular effects of Dopamine
higher risk of developing sinus tachycardia and ventricular arrhythmias
Isoproterenol Overview
- most potent sympathomimetic
- no alpha effects
- rapidly metabolized by COMT
- neees a continuous infusion
Clinical uses of Isoproterenol
increases the HR in patients with heart block
- useful before insertion of pacemaker
- useful in pulmonary hypertension and right ventricular dysfunction
Adverse effects of Isoproterenol
vasodilation and decreased blood pressure
- can lead to myocardial ischemia
Dobutamine overview
Potent Beta-1, weak Beta-2 and increasing effect on Alpha at higher doses
- racemix mixture
- decreases pulmonary vascular resistance
- inhibits HPV
Clnical uses for Dobutamine
can improve cardiac output in patients with CHF and wean patients off cardiopulmonary bypass
- stress testing
- pulmonary hypertension
Ephedrine Overview
indirect alpha and beta agonist
- resistant to MAO in the GI tract
- drug can be absored after oral administration
- does not produce hyperglycemia
- CNS stimulation occurs
Clincial use for Ephedrine
increases systemic blood pressure
- tachyphylaxis occus
- no longer drug of choice for deliveries
Cardiovascular effects of Ephedrine
- less potent in raising BP and lasts approximately 10x longer than epinephrine
- increases systolic and diastolic BP, HR, and CO
Tachyphylaxis
second dose of a drug is less intense than the first
- occurs with many sympathomimetics
Phenylephrine Overview
synthetic noncatecholamine that mimics the effects of Norepineprhine, but is less potent and longer lasting
- increases venoconstriction
- must be double diluted
- increases coronary perfusion without chronotropic side effects
- good for CAD and aortic stenosis
Cardiovascular effects of Phenylephrine
peripheral vasoconstriction and increases systemic blood pressure, while decreasing CO
Phenylephrine Toxicity Treatment
- direct acting vasodilator (alpha antagonist)
- Ex: Phentolamine
- beta blockers are contraindicated
Digoxin Overview
Used for supraventricular tachydysrhythmias (paroxysmal atrial tachycardia, a-fib, and a-flutter)
- decrease conduction through the AV node
- 10-30min IV onset
Narrow Therapeutic range for Digoxin
- Causes
- renal dysfunction
- hypoxemia
- hypokalemia
- hypercalcemia
- hypermagnesemia
- Diagnosis
- plasma concentration
- anorexia, nausea, vomiting
- EKG
- atrial and ventricular arrhythmias
- long PR or heart block
Digoxin Toxicity Treatment
- correct causes
- hypokalemia
- hypoxemia
- Phenytoin, lidocaine, or atropine
- treat cardiac dysrhythmias
- temporary pacemaker
- if complete heart block
Contraindications for Digoxin
- Hypertrophic obstructive cardiomypathy (HOCM)
- IHSS
- ASH
- increased contractility may exacerbate outflow obstruction
- Wolff-Parkinson-White syndrome
IHSS
idiopathic hypertrophic subaortic stenosis
ASH
asymmetric septal hypertrophy
WPW EKG
short PR interval with delta wave
Selective Phosphodiesterase Inhibitors
- increase cAMP in myocardial and vascular
- increased inward Ca2+ current
- increases contractility
- vasodilation
- effective in BB patients
- enhance actions of catecholamines
Effects of Phosphodiesterase Inhibitors
- decrease SVR, PVR, and CVP
- increase contractility (inotropy)
Uses for Calcium
- after massive transfusion
- CP bypass
- following parathyroidectomy
How should calcium chloride be given?
through a central line
- always aspirate first
(2) Alpha Antagonists
Phentolamine and Phenoxybenzamine
(4) Alpha-1 antagonists
- Prazosin (minipress)
- Doxazosin (cardura)
- Terazosin (hytrin)
- Tamulosin (flomax)
(2) Alpha-2 Agonists
Clonidine and Dexmedotomidine
(2) Combinded Alpha and Beta Antagonists
Labetolol and Carvedilol
(6) Calcium Channel Blockers
- Amlodipine
- Diltiazem
- Nicardipine
- Nifedipine
- Nimodipine
- Verapamil